Contact Us   Having technical issues or questions regarding this product?
Please Contact Us.
BEI Resources currently limits the total number of "Made to Order" items which can be ordered by a registrant to 10 "Made to Order" items per 6 month period. Please check the Availability Status on the items you are ordering and limit orders appropriately.
NR-2623  Vaccinia virus, Western Reserve, A33R Protein with C-Terminal Histidine Tag, Recombinant from Baculovirus
Price: All BEI Resources products are provided
at no cost to registered researchers.
Description: Western Reserve, A33R Protein with C-Terminal Histidine Tag, Recombinant from Baculovirus
Organism: Vaccinia virus
Biosafety Level: 1
Availability Status: In Stock
Store at: -80°C or colder
Contributor: GH Cohen, RJ Eisenberg
Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-2623 is a recombinant form of the A33R membrane glycoprotein (A33Rt; residues 58 to 185, C-terminal histidine-tagged) of the Western Reserve (WR) strain of vaccinia virus. The full length A33R protein is 185 residues (GenPept P68617). NR-2623 was produced in cabbage looper (Trichoplusia ni) insect larvae using a baculovirus expression vector system and was purified using nickel affinity chromatography.

NR-2623 was demonstrated to be functionally active based on its reactivity with mouse monoclonal antibody to A33R (BEI Resources NR-565).

Each vial contains approximately 1.0 mg of NR-2623 in 25 mM phosphate buffer (pH 7.0) containing 150 mM NaCl/50% glycerol (v/v).
Citations: Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Vaccinia Virus, Western Reserve, A33R Protein with C-Terminal Histidine Tag, Recombinant from Baculovirus, NR-2623."
Publications Citing
this Reagent:
Zhu, Q., et al. "Large Intestine-Targeted, Nanoparticle-Releasing Oral Vaccine to Control Genitorectal Viral Infection." Nat. Med. 18 (2012): 1291-1296. 22797811.

Yin, L., et al. "CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus-Vaccinated Humans." J. Immunol. 190 (2013): 6023-6033. PubMed: 23667112.
For a list of permits that may be required for shipping this product and to set the permit information preferences; please select a country from the drop down below.

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.

Return to Top

Notices and Disclaimers

BEI Resources products are intended for laboratory research purposes only. They are not intended for use in humans.

While BEI Resources uses reasonable efforts to include accurate and up-to-date information on this site, BEI Resources makes no warranties or representations as to its accuracy. Citations from scientific literature and patents are provided for informational purposes only. BEI Resources does not warrant that such information has been confirmed to be accurate.

Back to My Search